In the current study, we designed experiments to directly address if the addition of D1MT, an IDO inhibitor, adjunctive to TB chemotherapy improves the clearance of M. tuberculosis from the lungs of infected RMs and lowers the risk of TB disease. Here, IDO1 is linked to tuberculosis.